Production (Stage)
Janus Henderson Global Life Sciences Fund Class T
JAGLX
NASDAQ
| Weiss Ratings | JAGLX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Fair | |||
| Reward Grade | C | |||
| Risk Index | Fair | |||
| Risk Grade | C+ | |||
| Company Info | JAGLX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Provider | Janus Henderson | |||
| Manager/Tenure (Years) | Andy Acker (18), Daniel Lyons (2) | |||
| Website | http://janushenderson.com | |||
| Fund Information | JAGLX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Fund Name | Janus Henderson Global Life Sciences Fund Class T | |||
| Category | Health | |||
| Sub-Category | Healthcare Sector Equity | |||
| Prospectus Objective | Specialty - Health | |||
| Inception Date | Dec 31, 1998 | |||
| Open/Closed To New Investors | Open | |||
| Minimum Initial Investment | 2,500.00 | |||
| Minimum Subsequent Investment | -- | |||
| Front End Fee | -- | |||
| Back End Fee | -- | |||
| Dividends and Shares | JAGLX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Yield | 0.22% | |||
| Dividend | JAGLX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Yield (Forward) | 1.30% | |||
| Asset Allocation | JAGLX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash | 0.65% | |||
| Stock | 98.58% | |||
| U.S. Stock | 77.95% | |||
| Non-U.S. Stock | 20.63% | |||
| Bond | 0.00% | |||
| U.S. Bond | 0.00% | |||
| Non-U.S. Bond | 0.00% | |||
| Preferred | 0.24% | |||
| Convertible | 0.04% | |||
| Other Net | 0.50% | |||
| Price History | JAGLX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 2.18% | |||
| 30-Day Total Return | 2.15% | |||
| 60-Day Total Return | 5.76% | |||
| 90-Day Total Return | 0.83% | |||
| Year to Date Total Return | -1.00% | |||
| 1-Year Total Return | -10.12% | |||
| 2-Year Total Return | 5.60% | |||
| 3-Year Total Return | 19.49% | |||
| 5-Year Total Return | 33.62% | |||
| Price | JAGLX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Closing Price | -- | |||
| 1-Month Low Price | -- | |||
| 1-Month High Price | -- | |||
| 52-Week Low Price | -- | |||
| 52-Week Low Price (Date) | -- | |||
| 52-Week High Price | -- | |||
| 52-Week High Price (Date) | -- | |||
| NAV | JAGLX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Nav | $66.55 | |||
| 1-Month Low NAV | $65.05 | |||
| 1-Month High NAV | $66.84 | |||
| 52-Week Low NAV | $61.32 | |||
| 52-Week Low NAV (Date) | Apr 08, 2025 | |||
| 52-Week High NAV | $82.05 | |||
| 52-Week High Price (Date) | Aug 30, 2024 | |||
| Beta / Standard Deviation | JAGLX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.68 | |||
| Standard Deviation | 14.56 | |||
| Balance Sheet | JAGLX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Total Assets | 4.40B | |||
| Operating Ratios | JAGLX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Expense Ratio | 0.92% | |||
| Turnover Ratio | 35.00% | |||
| Performance | JAGLX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Last Bull Market Total Return | 8.11% | |||
| Last Bear Market Total Return | -8.29% | |||